MedPath

Inflammatory Status of Visceral Adipose Tissue in Obese Patients Related to Periodontitis Severity

Not Applicable
Conditions
Parodontitis
Obesity
Metabolism Disorders
Interventions
Other: NO PERIODONTITIS
Other: SEVERE PERIODONTITIS
Registration Number
NCT02853734
Lead Sponsor
Centre Hospitalier Universitaire de la Réunion
Brief Summary

The research aims to compare the inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitis, in order to establish a potential causal link between the severity of the bacterial contamination and insulin resistance.

Detailed Description

Recruitment of patients will be achieved in the department of digestive surgery. It will involve 122 patients with severe obesity undergoing bariatric surgery scheduled within the digestive surgery department. Patients recruited will be examined for evaluating the presence and severity of periodontitis, and separated into either group 1: for patients with moderate or severe periodontitis, and or group 2: for patients without or with mild periodontitis. The day before the surgery, blood sample will be collected for the analysis of circulating metabolic and inflammatory markers. Collection of stimulated saliva, periodontal sample and faeces samples (50 g) will also be carried out for bacteria determination. During the surgical procedure, a sample of visceral adipose tissue (50 g) will be collected and used for periodontal bacteria detection and inflammatory markers analyses.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
122
Inclusion Criteria
  • Patient eligible for bariatric surgery scheduled within the digestive surgery
  • Patient affiliated to Social Security system or equivalent
Exclusion Criteria
  • Treatment with steroids or anti-inflammatory drugs in progress (or stopped for less than one month)
  • Patients who received antibiotics within 3 months prior to the bariatric surgery for whatever duration
  • Dental current (or older than 3 months)
  • Participation in another research protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NO PERIODONTITISNO PERIODONTITISPeriodontal examination Biological samples collection: periodontal, saliva, blood, fecal, visceral adipose tissue
SEVERE PERIODONTITISSEVERE PERIODONTITISPeriodontal examination Biological samples collection: periodontal, saliva, blood, fecal, visceral adipose tissue
Primary Outcome Measures
NameTimeMethod
Inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitisConsecutively to visceral fat biopsy (day of surgery)

Measurements of major adipocytokines (Interleukine 6, Leptin, Adiponectin, Tumor Necrosis Factor-alpha, Monocyte Chemoattractant Protein-1, macrophage F4/80 receptor, CD11c, nuclear factor-kappa B, Toll Like Receptor 2/4 )

Secondary Outcome Measures
NameTimeMethod
Description of the metabolic profile of patients relative to periodontitis severityConsecutively to periodontal examination (day before surgery)

glycemia, insulinemia, glucose tolerance, plasma and HDL total cholesterol, triglycerides

Detection of DNA for at least one type of periodontal pathogens in adipose tissueConsecutively to visceral fat biopsy (day of surgery)

Aggregatibacter actinomycetemcomitans, Fusibacterium nucleatum, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola and Tannerella forsythia

Link between adipose tissue inflammatory status, bacterial contamination and metabolic profile of patientsConsecutively to periodontal examination and fat biopsy (day before surgery, day of surgery)

adipose tissue inflammatory status, periodontal bacterial contamination,diabetic disorders, lipid metabolic profile of patients

Link between the presence of periodontal pathogens in adipose tissue and their detection in saliva and plasmaConsecutively to periodontal examination and fat biopsy (day before surgery, day of surgery)

Detection of antibodies directed to periodontal bacteria in saliva and plasma

Trial Locations

Locations (1)

CHU de La Réunion

🇷🇪

Saint-Pierre, Réunion

© Copyright 2025. All Rights Reserved by MedPath